Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Lonza forms custom manufacturing division

21-Jul-2009

Related topics: Contract Manufacturing, Bulk ingredients

Lonza has combined its exclusive synthesis and biopharmaceutical businesses into a single unit to “enhance synergies in sales and marketing and on the operational side.”

The new division, known as Lonza custom manufacturing, consolidates the Swiss firm’s suite of R&D and production services for chemicals, intermediates, active pharmaceutical ingredients (API) and biotherapeutics.

Lonza will hope that the new group’s broad offering will be able to win contract manufacturing business from a diverse range of pharmaceutical players, particularly those seeking biomanufacturing and development solutions.

Stephen Kutzer and Uwe Boehlke, from Lonza’s biopharmaceutical and exclusive synthesis groups, will jointly lead the new unit.

Follow us on

Key Industry Events

Partnerships in Clinical Trials

Orlando, FL 32821 / Conference

Read more

Procurecon Pharma 2012

Zurich-Glattpark, 8152 / Conference and exhibition

Read more

Access our events listing